Editas Medicine, Inc.
CRISPR-RELATED METHODS AND COMPOSITIONS
Last updated:
Abstract:
Methods and compositions useful in targeting a payload to or editing a target nucleic acid are disclosed herein.
Status:
Application
Type:
Utility
Filling date:
24 Jul 2020
Issue date:
11 Feb 2021